Rite Aid (RAD) Nov. Comps Increase 5.1%

Rite Aid Corporation (NYSE: RAD) today announced sales results for November.

Monthly Sales

For the five weeks ended Nov. 29, 2014, same store sales increased 5.1 percent over the prior-year period. November front-end same store sales increased 0.7 percent. Pharmacy same store sales, which included an approximate 232 basis points negative impact from new generic introductions, increased 7.1 percent. Prescription count at comparable stores increased 4.2 percent over the prior-year period.

Total drugstore sales for the five-week period increased 5.6 percent to $2.571 billion compared to $2.434 billion for the same period last year. Prescription sales accounted for 69.7 percent of drugstore sales, and third party prescription sales represented 97.6 percent of pharmacy sales.

Quarterly Sales

Same store sales for the 13-week period ended Nov. 29, 2014 increased 5.4 percent over the prior-year period. Front-end same store sales increased 1.6 percent while pharmacy same store sales increased 7.2 percent. Prescription count at comparable stores increased 4.5 percent over the prior-year period.

Total drugstore sales for the 13 weeks ended Nov. 29, 2014 increased 5.1 percent with sales of $6.651 billion compared to $6.330 billion for the same period last year. Prescription sales represented 69.8 percent of total drugstore sales, and third party prescription sales represented 97.6 percent of pharmacy sales.

Year-to-Date

Same store sales for the 39-week period ended Nov. 29, 2014 increased 4.2 percent over the prior-year period. Front-end same store sales increased 0.9 percent while pharmacy same store sales increased 5.8 percent. Prescription count at comparable stores increased 3.5 percent over the prior-year period.

Total drugstore sales for the 39 weeks ended Nov. 29, 2014 increased 3.8 percent with sales of $19.553 billion compared to $18.844 billion for the same period last year. Prescription sales represented 69.0 percent of total drugstore sales, and third party prescription sales represented 97.5 percent of pharmacy sales.

You May Also Be Interested In

• Biogen (BIIB) tops earnings expectations but revenue falls short
• NVIDIA (NVDA) has agreed to acquire Run:ai
• Moderna (MRNA) Collaborates with OpenAI